In settlement of all outstanding claims in the litigation, Celgene said that it has agreed to provide Alvogen with a license to Celgene’s patents that is required to manufacture and sell certain volume-limited amounts of generic lenalidomide in the United States.

A New Jersey judge has ruled that Hoboken lacked the authority to accept $3.485 million in “community giveback” payments from the hotel's redeveloper.

Bayer AG lost its second trial over claims that its Roundup weed killer product causes cancer.

A jury in Middlesex County Superior Court cleared Johnson & Johnson of liability in a lawsuit brought by a man who said that asbestos in the company’s talcum powder products caused his mesothelioma.

Both Mark Manigan and Deb Lienhardt come to the system from the health law practice of Roseland-based Brach Eichler.

Bayer and Johnson & Johnson announced on Monday the two companies have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million.

The suit filed Friday by the New Jersey Attorney General marks the first such lawsuit against a ghost gun distributor.

State lawmakers advanced, and Gov. Phil Murphy approved, a bill last summer allowing Jersey City to impose and collect a one percent payroll tax. The City Council approved the tax last year, which went into effect on Jan. 1.

S. Jason Teele brings with him two decades of experience at New Jersey firms with a focus on corporate restructuring, commercial litigation and transactional matters involving distressed businesses.